ILMN | tickerfilter.com

Fundamental analysis

25%

Profitability 0%

Dept financing 20%

Liquidity 65%

Performance 42%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-2.23%

1 Month

-16.15%

3 Months

-41.79%

6 Months

-35.11%

1 Year

-34.39%

2 Year

-62.79%

Key data

Stock price

$84.05

P/E Ratio

0.00

DAY RANGE

$82.74 - $84.81

EPS

-$7.67

52 WEEK RANGE

$80.18 - $156.66

52 WEEK CHANGE

-$34.20

MARKET CAP

21.454 B

YIELD

N/A

SHARES OUTSTANDING

159.300 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

1.07

PUBLIC FLOAT

AVERAGE 10 VOLUME

$2,766,983

AVERAGE 30 VOLUME

$3,073,328

Company detail

CEO: Francis A. deSouza
Region: US
Website: illumina.com
Employees: 11,500
IPO year: 2000

Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and Asia-Pacific region.

ILMN - ILLUMINA, INC.